by 
The glucose excipient market has been growing steadily over the past few years. Glucose is one of the most commonly used carbohydrate excipients in oral solid dosage forms. It imparts properties like adhesion, moisture retention, coating integrity and flowability to pharmaceutical formulations. Glucose is especially useful in tablet manufacturing as it aids the compaction and compression process. The increasing prevalence of diseases like diabetes, cancer and respiratory illnesses has fuelled the demand for drugs globally. This in turn is driving the need for excipients like glucose that help in manufacturing formulations effectively and delivering drugs safely to patients. The global glucose excipient market provides cost-effective and stable formulations.
Market key trends:
One of the key trends in the glucose excipient market is the focus on developing new grades with enhanced properties. Manufacturers are innovating to offer glucose grades tailored for specific drug delivery applications. For example, there is a growing demand for glucose polymers and oligomers that allow controlled or sustained release of drugs. This helps in improving patient compliance. Another notable trend is the widening of product portfolio by major players. Along with standard glucose grades, companies are introducing value-added products like pregelatinized starch grades. This is helping them expand market share. Stringent regulatory norms regarding excipient quality and safety are also spurring innovations. Overall, advancements in glucose excipient technology will be crucial for addressing the needs of the pharmaceutical industry.
Porter’s Analysis
Threat of new entrants: The glucose excipient market has moderate threat of new entrants due to high capital requirements needed to establish large scale manufacturing facilities and stringent regulations.
Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutes and significant number of players operating in the market.
Bargaining power of suppliers: Suppliers have low to moderate bargaining power due to commoditization of raw materials.
Threat of new substitutes: Threat of new substitutes is low as glucose derivatives are preferred excipients over other substitutes.
Competitive rivalry: The market is highly competitive with presence of major players and newer companies introducing innovative products.
Key Takeaways
The global glucose excipient market is expected to witness high growth over the forecast period of 2023 to 2030.
The key regions driving market growth include North America and Europe. North America currently dominates the market and is expected to continue its dominance due to high healthcare spending and presence of major players.
Key players operating in the glucose excipient market are Polident D.O.O., Amt Medical SRL, Ivoclar Vivadent, VITA Zahnfabrik H. Rauter GmbH & Co. KG., Merz Dental GmbH, 3D Diagnostix Inc. The market is highly fragmented with various players focusing on new product launches and mergers & acquisitions to gain competitive edge. For instance, in 2023, VITA Zahnfabrik acquired 3M EPICENTALS to expand its presence in dental CAD/CAM and 3D printing segment.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
